Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Return on Capital Employed (2016 - 2020)

Historic Return on Capital Employed for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Q4 2020 value amounting to 0.32%.

  • Syndax Pharmaceuticals' Return on Capital Employed rose 7900.0% to 0.32% in Q4 2020 from the same period last year, while for Dec 2020 it was 0.32%, marking a year-over-year increase of 7900.0%. This contributed to the annual value of 0.6% for FY2024, which is 1400.0% down from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.32% for Q4 2020, which was up 7900.0% from 0.39% recorded in Q3 2020.
  • Syndax Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.22% for Q2 2016, and its period low was 1.12% during Q4 2019.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.53% (2017), whereas its average is 0.63%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -4900bps in 2018, then skyrocketed by 7900bps in 2020.
  • Syndax Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.42% in 2016, then dropped by -27bps to 0.54% in 2017, then crashed by -90bps to 1.02% in 2018, then decreased by -9bps to 1.12% in 2019, then skyrocketed by 71bps to 0.32% in 2020.
  • Its last three reported values are 0.32% in Q4 2020, 0.39% for Q3 2020, and 0.43% during Q2 2020.